Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer.

Bange, Erin; Marmarelis, Melina E; Hwang, Wei-Ting; Yang, Yu-Xiao; Thompson, Jeffrey C; Rosenbaum, Jason; Bauml, Joshua M; Ciunci, Christine; Alley, Evan W; Cohen, Roger B; Langer, Corey J; Carpenter, Erica; Aggarwal, Charu

Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer.

Bange, Erin; Marmarelis, Melina E; Hwang, Wei-Ting; Yang, Yu-Xiao; Thompson, Jeffrey C; Rosenbaum, Jason; Bauml, Joshua M; Ciunci, Christine; Alley, Evan W; Cohen, Roger B; Langer, Corey J; Carpenter, Erica; Aggarwal, Charu.

Afiliação

Bange E; University of Pennsylvania, Philadelphia, PA.
Marmarelis ME; University of Pennsylvania, Philadelphia, PA.
Hwang WT; University of Pennsylvania, Philadelphia, PA.
Yang YX; University of Pennsylvania, Philadelphia, PA.
Thompson JC; University of Pennsylvania, Philadelphia, PA.
Rosenbaum J; University of Pennsylvania, Philadelphia, PA.
Bauml JM; University of Pennsylvania, Philadelphia, PA.
Ciunci C; University of Pennsylvania, Philadelphia, PA.
Alley EW; University of Pennsylvania, Philadelphia, PA.
Cohen RB; University of Pennsylvania, Philadelphia, PA.
Langer CJ; University of Pennsylvania, Philadelphia, PA.
Carpenter E; University of Pennsylvania, Philadelphia, PA.
Aggarwal C; University of Pennsylvania, Philadelphia, PA.

JCO Precis Oncol ; 32019.

Article em En | MEDLINE | ID: mdl-31428721

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Panamá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google